Workflow
Ionis Pharmaceuticals, Inc. (IONS) Discusses Detailed Phase III Results for Olezarsen in Severe Hypertriglyceridemia - Slideshow (NASDAQ:IONS) 2025-11-10

根据提供的文档内容,该文档不包含任何与公司或行业相关的实质性信息[1]